Randomized study of vinorelbine–gemcitabine versus vinorelbine–carboplatin in patients with advanced non-small cell lung cancer by Tan, E.H., Szczesna, A., Krzakowski, M., Macha, H.N., Gatzemeier, U., Mattson, K., Wernli, M., Reiterer, P., Hui, R., Pawel, J. Von, Bertetto, O., Pouget, J.C., Burillon, J.P., Parlier, Y., Abratt, R.

Get full text

Oral vinorelbine given as monotherapy to advanced, elderly NSCLC patients: a multicentre phase II trial by Gridelli, C., Manegold, C., Mali, P., Reck, M., Portalone, L., Castelnau, O., Stahel, R., Betticher, D., Pless, M., Pons, J. Terrassa, Aubert, D., Burillon, J.-P., Parlier, Y., De Marinis, F.

Get full text

Vinorelbine and Cisplatin in Advanced Squamous Cell Carcinoma of the Cervix: The South African Experience by GOEDHALS, Louis, FALKSON, Geoffrey, SMITH, Brenda Lynn, FALKSON, Carla Isadora, GASMI, Jamal, LATEGAN, Andries, BURILLON, Jean-Philippe, HIS, Patricia

Get full text

A phase II trial of vinorelbine and cisplatin in previously intreated inoperable non-small cell lung cancer by Shih, JF, Perng, RP, Chen, YM, Chou, KC, PW, JK, Burillon, JP, Ducrocq, M, Delgado, FM

Get full text

Phase II trial of i.v. navelbine (NVB) and cisplatin (CDDP) in inoperable locally advanced or disseminated NSCLC by Goedhals, L, Bezwoda, W, Vorobiof, D, Van Der Merwe, A, Jordaan, JP, Barnardt, P, Bassompierre, P, Lategan, A, Burillon, J-P, Danel, P

Get full text